⌘K

Login Start Free

Home/Filings/4/0001053369-15-000011

4//SEC Filing

ELITE PHARMACEUTICALS INC /NV/ 4

Accession 0001053369-15-000011

$ELTPCIK 0001053369operating

View on SEC.gov Company Profile

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 9:15 PM ET

Size

21.9 KB

Accession

0001053369-15-000011

Insider Transaction Report

Form 4

Period: 2015-04-03

ELITE PHARMACEUTICALS INC /NV/ELTP

NIGALAYE ASHOK G

DirectorChief Scientific Officer10% Owner

Transactions

Other
Warrants
2015-04-03−40,000,000→ 0 total(indirect: By LLC)
Exercise: $0.06From: 2011-03-31Exp: 2018-03-31→ Common Stock (40,000,000 underlying)
Other
Warrants
2015-04-03−4,000,000→ 0 total(indirect: By LLC)
Exercise: $0.06From: 2011-04-25Exp: 2018-04-25→ Common Stock (4,000,000 underlying)
Other
Warrants
2015-04-03−2,454,665→ 0 total(indirect: By LLC)
Exercise: $0.06From: 2009-06-03Exp: 2016-06-03→ Common Stock (2,454,665 underlying)
Other
Warrants
2015-04-03−6,726,999→ 0 total(indirect: By LLC)
Exercise: $0.06From: 2009-10-30Exp: 2016-10-30→ Common Stock (6,726,999 underlying)
Other
Warrants
2015-04-03+2,454,665→ 2,454,665 total
Exercise: $0.06From: 2009-06-03Exp: 2016-06-03→ Common Stock (2,454,665 underlying)
Other
Warrants
2015-04-03+6,726,999→ 15,349,042 total
Exercise: $0.06From: 2009-10-30Exp: 2016-10-30→ Common Stock (6,726,999 underlying)
Other
Warrants
2015-04-03+2,684,137→ 2,684,137 total
Exercise: $0.06From: 2011-03-31Exp: 2018-03-31→ Common Stock (2,684,137 underlying)
Other
Warrants
2015-04-03+4,000,000→ 4,000,000 total
Exercise: $0.06From: 2011-04-25Exp: 2018-04-25→ Common Stock (4,000,000 underlying)

Footnotes (3)

[F1]Disposition of warrants to its members
[F2]Ashok Nigalaye is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI")(which is controlled by EP), which is a 10% owner of the issuer, and also serves as a director of the issuer.
[F3]Ashok Nigalaye is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which is a 10% owner of the issuer, and also serves as a director of the issuer. Reporting person received these securities pursuant to a distribution by EI to members of Epic Pharma, LLC.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeoperating

IncorporatedNJ

Related Parties

1

filerCIK 0001053369

Filing Metadata

Form type: 4
Filed: Apr 6, 8:00 PM ET
Accepted: Apr 7, 9:15 PM ET
Size: 21.9 KB

View on SEC.gov